Novo Nordisk Operating Income Over Time
| NOVA Stock | EUR 32.15 0.45 1.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Novo Nordisk Performance and Novo Nordisk Correlation. Novo |
Cross Equities Operating Income Analysis
Compare Novo Nordisk AS and related stocks such as MUTUIONLINE, TYSON FOODS A, and BG Foods Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MNL | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 39 M | 44.7 M | 49.7 M | 61.8 M | 70 M | 62.5 M | 58.7 M | 70.3 M | 80.9 M | 60 M |
| TF7A | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.9 B | 3.1 B | 2.8 B | 3.1 B | 4.4 B | 4.4 B | 386 M | 1.4 B | 1.4 B | 1.3 B | 2.1 B |
| DHR | 259.4 M | 259.4 M | 259.4 M | 259.4 M | 259.4 M | 259.4 M | 259.4 M | 239.4 M | 163.8 M | 203.8 M | 276.4 M | 219.2 M | 198 M | 238.7 M | 213.4 M | 192.1 M | 178.9 M |
| 4P7 | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 126.3 M | 171.3 M | 210.3 M | 235.4 M | 47.8 M | 21.1 M | (14.1 M) | 61.4 M | 55.3 M | 91.3 M |
| P5P | 661 M | 661 M | 661 M | 661 M | 708 M | 685 M | 878 M | 1.2 B | 1.6 B | 1.7 B | 1.8 B | 2.6 B | 2.6 B | 2.4 B | 2.9 B | 3.3 B | 1.8 B |
| ZVF | 2.1 T | 2.1 T | 2.1 T | 2.1 T | 2.1 T | 2.1 T | 2.1 T | 1.6 T | 781.5 B | 601.4 B | 1.6 T | 3.2 T | 2.9 T | 2 T | 3.8 T | 4.4 T | 2.3 T |
Novo Nordisk AS and related stocks such as MUTUIONLINE, TYSON FOODS A, and BG Foods Operating Income description
Operating Income is the amount of profit realized from Novo Nordisk AS operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Novo Nordisk AS is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Novo Nordisk AS | NOVA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Novo Alle 1, |
| Exchange | Frankfurt Exchange |
EUR 32.15
Check out Novo Nordisk Performance and Novo Nordisk Correlation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.